Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

multi-channel

- PMLiVE

Managing value: Why early asset development and commercialisation are important

Realising the full value of your asset - clinically and commercially - means thinking beyond the pure scientific value, even at the very early stages of development

- PMLiVE

AstraZeneca embarks on oncology research access project

Invites companies to join molecular data resource consortium

- PMLiVE

From push to pull: what makes effective multichannel marketing?

How designing CME becomes a listen and learn exercise as physicians are adapting to social media

- PMLiVE

Gilead launches European hep C awareness drive

Aims to highlight significance of cure through patient storytelling initiative

- PMLiVE

Making a difference with medical education

Curiosity drives us, tenacity allows us to rise and creativity enables us to shine

- PMLiVE

Brain training ‘could cut dementia risk’, says study

Findings suggest computerised speed of processing training can reduce cognitive decline by 48 percent

Lucid Group take time out for work and play at their annual Summer Meeting

Lucid Group may be an award-winning medical education agency, packed with industry-leading talent, but it still understands how important it is to provide the best customer experience possible. 2015 was an...

Lucid Group Communications Limited

- PMLiVE

International AIDS Society rebrands with focus on patient stories

The Partners Health revamps branding as part of marketing drive

- PMLiVE

Ashley Comms and Southwood Research team up

Med comms agency joins forces with clinical and regulatory consultancy

- PMLiVE

The Netherlands leads Europe for future health

And benchmarking report finds UAE best placed to meet healthcare challenges

- PMLiVE

Blue Latitude Health expands into the US

New York City office will be led by James Atherton

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links